Observable entity

Code	`363787002`
Semantic tag	observable entity
Module	international
Definition	primitive
Effective time	20020131

562310002371087-Aminonitrazepam mass concentration in oral fluid observable entity

67821000237101ADAMTS13 (disintegrin and metalloproteinase with thrombospondin type 1 motif 13) enzyme activity in plasma observable entity

105727008Age AND/OR growth period observable entity

143381000237103Allergy clinical laboratory observable observable entity

5541000237100Alternative (AP100) complement pathway haemolytic activity percent in serum observable entity

1285474005Antimicrobial susceptibility of organism by matrix assisted laser desorption ionisation time of flight mass spectrometry observable entity

782487009Assessment score observable entity

364681000119104Benzodiazepine in urine by confirmatory technique observable entity

364684009Body product observable observable entity

50371000237104CMV (cytomegalovirus) DNA nucleic acid amplification qualitative result observable entity

50221000237108CMV (cytomegalovirus) antibody in serum qualitative result observable entity

6411000237109Calculated serum osmolarity molar concentration in serum observable entity

67921000237109Calculus weight observable entity

67561000237109Carbonate and phosphate percent calculus content observable entity

143441000237100Clinical chemistry observable observable entity

363788007Clinical history/examination observable observable entity

491000124103Clinical performance measure observable entity

51151000237100Clue cells in high vaginal swab microscopy qualitative result observable entity

143451000237102Coagulation laboratory observable observable entity

1464771000000108Coefficient of variation of mean substance concentration of glucose in capillary blood by self-monitoring of blood glucose using blood glucose meter observable entity

1464761000000101Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device observable entity

1464971000000106Coefficient of variation of mean substance concentration of glucose in capillary blood using point-of-care testing device observable entity

56881000237106Collagen/adrenaline closure time in blood observable entity

1285434004Concentration of neurotransmitter in blood observable entity

1268647006Cycle threshold for nucleic acid detection in specimen using real-time polymerase chain reaction observable entity

1285172003Detection and differentiation of antibody to human immunodeficiency virus type 1 and human immunodeficiency virus type 2 by immunoassay observable entity

364321000119106Detection of Legionella pneumophila antigen in urine observable entity

376111000119104Detection of Neisseria gonorrhoeae nucleic acid by amplified probe technique observable entity

871562009Detection of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) observable entity

364351000119103Detection of Streptococcus pneumoniae antigen in urine observable entity

1290195007Detection of antibody to infective organism observable entity

1260282001Detection of opiate by screening method observable entity

375911000119106Differential count of white blood cells by automated method observable entity

376201000119106Differential count of white blood cells by manual method observable entity

364401000119105Direct antiglobulin test of cord blood observable entity

441870009Disease activity score using 28 joint count observable entity

26421000237108Docosanoate (C22) molar concentration in plasma observable entity

363819003Drug therapy observable observable entity

60881000237101EBV (Epstein-Barr virus) DNA nucleic acid amplification qualitative result observable entity

391000237102Eicosatrienoic acid molar concentration in serum observable entity

438950009Environment observable observable entity

49941000237104Epithelial cells in mid-stream urine microscopy qualitative result observable entity

58481000237107Ethyl sulphate mass concentration in hair observable entity

53931000237106Euglobulin clot lysis time time in blood observable entity

414237002Feature of entity observable entity

143461000237104Fertility testing observable observable entity

53791000237109Fibrinogen calibration curve observable entity

143481000237106Fluid chemistry observable observable entity

1281000237107Free beta HCG (human chorionic gonadotropin) multiple of the median in serum observable entity

246464006Function observable entity

50571000237109Fungal precipitin in plasma qualitative result observable entity

65201000237103Fungal precipitin in serum qualitative result observable entity

278844005General clinical state observable entity

373211000119100Giardia lamblia antigen by enzyme immunoassay observable entity

1464891000000104Glucose Management Indicator expressed as substance concentration ratio observable entity

372731000119106Glucose in blood one hour after glucose dose in pregnancy observable entity

372661000119106Glucose in blood one hour postprandial observable entity

3381000237101Glycophorin count percent in plasma observable entity

50211000237104HCV (hepatitis C virus) antibody in serum qualitative result observable entity

3741000237106HVMA (homovanillylmandelic acid) molar concentration in 24 hr urine observable entity

364709006Haematology observable observable entity

57731000237101Haemolysis index observable entity

52441000237103Hepatitis B virus DNA nucleic acid amplification qualitative result observable entity

1157167001Histologic grade of dysplasia at proximal surgical margin observable entity

51761000237101Hyaline casts in mid-stream urine microscopy qualitative result observable entity

55461000237109Icterus index ordinal value in serum observable entity

423901009Identification code observable entity

1285654008Identification of bacteria by matrix assisted laser desorption ionisation time of flight mass spectrometry observable entity

363891000119100Identification of bacteria in sputum by culture observable entity

1285667006Identification of fungus by matrix assisted laser desorption ionisation time of flight mass spectrometry observable entity

365971000119107Identification of organism in smear by Gram stain observable entity

372431000119101Identification of organism in wet smear by potassium hydroxide preparation observable entity

375771000119100Identification of ova and parasites in faecal smear by concentration and trichrome stain observable entity

399060005Imaging observable observable entity

365331000119108Immunoglobulin G antibody to cyclic citrullinated peptide observable entity

1285481003Indocyanine green clearance rate observable entity

373451000119103Interferon gamma in blood by Mycobacterium tuberculosis antigen stimulation observable entity

243814003Interpretation of findings observable entity

2991000237107Kappa cells percent in serum observable entity

3771000237102Keratin arbitrary concentration in serum observable entity

409599009Laboratory biosafety level observable entity

372461000119109Lactate in blood observable entity

2541000237108Lambda cells percent in serum observable entity

1284805008Length of cross section of myometrium in uterus specimen observable entity

50401000237102Leucocytes in mid-stream urine microscopy qualitative result observable entity

372361000119104Low density lipoprotein cholesterol by direct assay observable entity

364108009Lymph node observable observable entity

371671000119106Major crossmatch compatibility by immediate spin technique observable entity

1464921000000107Mean duration of hypoglycaemic episodes in minutes observable entity

1465041000000100Mean number of point-of-care capillary blood glucose measurements per day observable entity

1464931000000109Mean number of self-monitored capillary blood glucose measurements per day observable entity

1597771000000108Mean time between replacement of continuous subcutaneous insulin infusion catheter in days observable entity

1597781000000105Mean time between replacement of insulin infusion patch pump in days observable entity

1240461000000109Measurement of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antibody observable entity

1240471000000102Measurement of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antigen observable entity

1371017004Measurement of aminotransferase observable entity

1285331008Measurement of heme oxygenase-1 observable entity

54031000237108Metamyelocyte percent count in blood observable entity

1380208009Method of Gleason scoring system for grading malignant neoplasm of prostate technique used to grade neoplasm observable entity

57031000237104Methylglutarylcarnitine molar concentration in plasma observable entity

143471000237109Microbiology laboratory observable observable entity

143491000237108Molecular pathology observable observable entity

414755005Molecular, genetic AND/OR cellular observable observable entity

397793000Monitoring features observable entity

1290531000000106Monkeypox virus qualitative result observable entity

363847004Movement observable observable entity

1873921000000106Multi-cancer early detection highest scored cancer signal origin by machine learning-based classifier observable entity

1873931000000108Multi-cancer early detection second highest scored cancer signal origin by machine learning-based classifier observable entity

55511000237106NK (natural killer) T lymphocyte percent count in blood observable entity

1364091000000101NPEWS (National Paediatric Early Warning Score) chart used observable entity

52641000237100Naive B lymphocyte percent count in blood observable entity

55471000237104Naive T lymphocyte percent count in blood observable entity

30121000237100Neurokinin A molar concentration in plasma observable entity

53001000237101Non-switched memory B lymphocyte percent count in blood observable entity

13861000237103Normirtazepine mass concentration in plasma observable entity

16151000237103Normirtazepine mass concentration in serum observable entity

1464911000000101Number of clinically significant hypoglycaemic episodes recorded by continuous glucose monitoring device observable entity

1465031000000109Number of clinically significant hypoglycaemic episodes recorded by point-of-care monitoring of capillary blood glucose observable entity

1464901000000103Number of clinically significant hypoglycaemic episodes recorded by self-monitoring of capillary blood glucose observable entity

31000237108Number of days abstinence prior to semen sample production observable entity

702748008Number of occurrences observable observable entity

1234806008Observation using immunohistochemistry observable entity

11861000237102Oestradiol molar concentration in plasma observable entity

376261000119107Opiate in urine by confirmatory technique observable entity

1955891000000109Oral morphine equivalent estimated total daily dose observable entity

2601000237109Oxcarbazepine metabolite mass concentration in serum observable entity

1156597009Parameter observable entity

54871000237100Patient height observable entity

55491000237100Patient weight observable entity

1515761000000107Percentage of continuous glucose monitoring sensor failures to total sensors applied recorded by subject of record observable entity

1465001000000103Percentage of readings above level 1 hyperglycaemic threshold to total point-of-care capillary blood glucose readings using blood glucose meter observable entity

1464861000000105Percentage of readings above level 1 hyperglycaemic threshold to total self-monitored capillary blood glucose readings using blood glucose meter observable entity

1464991000000105Percentage of readings above level 2 hyperglycaemic threshold to total point-of-care capillary blood glucose readings using blood glucose meter observable entity

1464851000000107Percentage of readings above level 2 hyperglycaemic threshold to total self-monitored capillary blood glucose readings using blood glucose meter observable entity

1465021000000107Percentage of readings below level 1 hypoglycaemic threshold to total point-of-care capillary blood glucose readings using blood glucose meter observable entity

1464881000000101Percentage of readings below level 1 hypoglycaemic threshold to total self-monitored capillary blood glucose readings using blood glucose meter observable entity

1465011000000101Percentage of readings below level 2 hypoglycaemic threshold to total point-of-care capillary blood glucose readings using blood glucose meter observable entity

1464871000000103Percentage of readings below level 2 hypoglycaemic threshold to total self-monitored capillary blood glucose readings using blood glucose meter observable entity

1464981000000108Percentage of readings in target range to total point-of-care capillary blood glucose readings using blood glucose meter observable entity

1464841000000109Percentage of readings in target range to total self-monitored capillary blood glucose readings using blood glucose meter observable entity

1464941000000100Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive continuous glucose monitoring device observable entity

1597801000000106Percentage of successful data capture time to total expected wear time of insulin pump observable entity

1464801000000106Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device observable entity

1464791000000107Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device observable entity

1464831000000100Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device observable entity

1464821000000102Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device observable entity

1597811000000108Percentage of time in closed loop to total expected wear time of continuous automated insulin delivery system observable entity

1464781000000105Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device observable entity

1597881000000101Percentage of time spent by continuous automated insulin delivery system in low glucose suspend observable entity

1597891000000104Percentage of time spent by continuous automated insulin delivery system in predictive low glucose suspend observable entity

1597871000000103Percentage of time spent by insulin pump in manual suspend observable entity

58051000237105Plasma cells percent count in bone marrow aspirate observable entity

56801000237103Plasmablasts percent count in blood observable entity

43871000237100Plasmodium falciparum antigen arbitrary concentration in serum observable entity

3181000237104Platelet distribution width percent in blood observable entity

409652008Population statistic observable entity

351000124102Prescription observable observable entity

1268771007Presence of Helicobacter pylori in stool observable entity

1363298005Presence of atelectasis and/or obstructive pneumonitis extending to hilar structure of resected lung specimen observable entity

1306911009Presence of macroscopic perforation of colorectum observable entity

1269296000Presence of macroscopic perforation of small intestine by primary malignant neoplasm of small intestine observable entity

1240404008Presence of microcalcification in excised breast specimen observable entity

1240403002Presence of necrosis in excised breast specimen observable entity

1264290008Presence of thrombus in renal vein observable entity

375701000119105Presence of white blood cells in stool observable entity

415178003Process observable entity

1145211006Proliferative mass observable observable entity

58041000237107Prostate health index observable entity

50761000237108Pus cells in mid-stream urine microscopy qualitative result observable entity

26901000237105Pyridinium crosslinks molar concentration in serum observable entity

1854971000000106Qualitative result of cancer methylation profile in cell free deoxyribonucleic acid by next generation sequencing observable entity

228859002Radiation therapy observable observable entity

15141000237109Red blood cell count in fluid observable entity

568131000005103Rhesus antibody observable observable entity

374451000119101Rheumatoid factor in serum observable entity

1255619009Risk level observable entity

374591000119105Rubella virus antibody by screening latex agglutination observable entity

50451000237101Semen viscosity qualitative result observable entity

56091000237100Small bowel biopsy weight in small intestine specimen observable entity

611000237104Smear cells percent in blood observable entity

365451000119108Smooth muscle actin immunoglobulin G antibody observable entity

160476009Social / personal history observable observable entity

364708003Specimen observable observable entity

1464751000000104Standard deviation of mean substance concentration of glucose in capillary blood by self-monitoring of blood glucose using blood glucose meter observable entity

1464741000000102Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device observable entity

1464961000000104Standard deviation of mean substance concentration of glucose in capillary blood using point-of-care testing device observable entity

408655002Status of intactness of mesorectal specimen observable entity

1264293005Status of intactness of renal capsule in excised kidney specimen observable entity

373063009Substance observable observable entity

396631001Surgical margin observable observable entity

52931000237101Switched memory B lymphocyte percent count in blood observable entity

364713004Temporal observable observable entity

375091000119101Thiamine in whole blood observable entity

56661000237103Thiocyanate molar concentration in serum observable entity

143531000237108Toxicology laboratory observable observable entity

53281000237104Transitional B lymphocyte percent count in blood observable entity

374971000119102Treponema pallidum antibody by screening enzyme immunoassay observable entity

1364521000000106Trigger factor to activate care plan observable entity

54451000237105Turbidity index observable entity

58601000237101Unconjugated E2 (oestradiol) molar concentration in serum observable entity

143541000237101Urinalysis observable observable entity

25761000237100sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor) mass concentration ratio in serum observable entity

Parents (1)

Children (202)